Kate McKinley bought $30k of RANI
Chief Business Officer at Rani Therapeutics Holdings, Inc.. 17,960 shares at an average of $1.67, traded Dec 13, 2024, filed Dec 16, 2024.
Score components
- +15RoleOfficer
- +5Trade size$30k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -17.6%, 3m -3.1%, 6m -67.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-136787, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 13, 2024 | POpen-market purchase Class A Common Stock | +17,960 | $1.67 | $30k | 17,960 | Dec 16, 2024 |
Related signals
Other insiders at Rani Therapeutics Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 52Moderate | RANIbuy Rani Therapeutics Holdings, Inc. | Mir A Imran director, owner | $1.3M 2,083,334 shares | - | |
| 57Moderate | RANIsell Rani Therapeutics Holdings, Inc. | South Cone Investments Limited Partnership owner | $16M 5,923,000 shares | -71% | |
| 33Weak | Rani Therapeutics Holdings, Inc. | Talat Imran Chief Executive Officer | $20k 10,296 shares | +2% | |
| 47Moderate | RANIsell Rani Therapeutics Holdings, Inc. | South Cone Investments Limited Partnership owner | $10M 3,829,360 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.